Remove 2022 Remove Clinical Trials Remove Conditions
article thumbnail

MyMD Pharmaceuticals Subsidiary Oravax Medical Preparing to Commence Clinical Trials for Oral COVID-19 Vaccine

Cannabis Law Report

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today reported that its subsidiary Oravax Medical Inc. Oravax”), partially owned with its majority partner Oramed Pharmaceuticals Inc. About Oravax Medical.

article thumbnail

Incannex (ASX: IHL) partners with Procaps to develop cannabis medicine for clinical trial on sleep apnea

Cannabis Law Report

The agreement between the two companies will see Procaps making IHL-42X for Incannex’s Phase 2, Phase 3, and open-label clinical trials. If these trials are successful and IHL-42X is approved for the market, Procaps will also make IHL-42X for patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Press Release: atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions

Cannabis Law Report

Development is underway with clinical trials expected to begin in the second half of 2022. “SalA is a great product candidate that magnificently matches the criteria we strive for, with recognized synergies across the atai platform.”.

article thumbnail

Cannabis as a cancer cure: what is the research and where is it going?

The Cannigma

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. The answer: Maybe!

article thumbnail

CBD Market Report

Project CBD

Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. Available at: [link] Accessed October 17, 2022. Accessed October 17, 2022. February 2, 2022.

CBD 144
article thumbnail

New Trial Suggests Powerful Psilocybin May Ease Stress Before MRIs

Veriheal

A fascinating new clinical trial demonstrates how this psychedelic compound could make people significantly more comfortable while undergoing MRIs or similar procedures. However, it is important to note that the study took place with a small sample size under controlled conditions. What Is an MRI?

article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

The state bill would start the process of legalizing centers for veterans and first responders to receive psilocybin and MDMA (a synthetic psychedelic) to treat mental health conditions like PTSD. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Utah In March 2022, Gov.